A French start-up company plans to revolutionize the treatment of age-related macular degeneration (AMD) with a new generation retinal implant.
160 million people worldwide are affected by dry AMD. 2-5% of all Dry-AMD is Geographic Atrophy which there is currently no treatment available. During the « Journées nationales de la macula » November 23rd to 27th, 2020, Pleine Vie dedicates a piece to Pixium Vision and its Prima system.